Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy.
Saved in:
| Title: | Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy. |
|---|---|
| Authors: | Zhang M; School of Synthetic Biology and Biomanufacturing, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, China.; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Yuan H; School of Synthetic Biology and Biomanufacturing, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, China., Pan X; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Li X; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Wang Z; School of Synthetic Biology and Biomanufacturing, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, China., Zhang S; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Gu Z; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Hu B; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Qu X; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Wang Q; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Gu X; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Wang B; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Cao Y; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Mu G; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Kang G; School of Synthetic Biology and Biomanufacturing, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, China., de Marco A; Laboratory for Environmental and Life Sciences, University of Nova Gorica, Nova Gorica, Slovenia., Zhou X; China Resources Biopharmaceutical Company Limited, Shenzhen, China., Huang H; School of Synthetic Biology and Biomanufacturing, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 10; Vol. 17, pp. 1861537. Date of Electronic Publication: 2026 Jun 10 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
